1-8 of 8
Alice L. Yu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032

Available to Purchase
Alice L. Yu, Andrew L. Gilman, M. Fevzi Ozkaynak, Arlene Naranjo, Mitchell B. Diccianni, Jacek Gan, Jacquelyn A. Hank, Ayse Batova, Wendy B. London, Sheena C. Tenney, Malcolm Smith, Barry L. Shulkin, Marguerite Parisi, Katherine K. Matthay, Susan L. Cohn, John M. Maris, Rochelle Bagatell, Julie R. Park, Paul M. Sondel
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (8): 2179–2189.
https://doi.org/10.1158/1078-0432.CCR-20-3909
Published: 15 April 2021
View articletitled, Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032
Open the PDF for Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032 in another window
Includes: Supplementary data
Journal Articles

A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma

Free
Wayne L. Furman, Sara M. Federico, Mary Beth McCarville, Barry L. Shulkin, Andrew M. Davidoff, Matthew J. Krasin, Natasha Sahr, April Sykes, Jianrong Wu, Rachel C. Brennan, Michael William Bishop, Sara Helmig, Elizabeth Stewart, Fariba Navid, Brandon Triplett, Victor M. Santana, Armita Bahrami, Gwendolyn Anthony, Alice L. Yu, Jacquelyn Hank, Stephen D. Gillies, Paul M. Sondel, Wing H. Leung, Alberto S. Pappo
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (21): 6320–6328.
https://doi.org/10.1158/1078-0432.CCR-19-1452
Published: 01 November 2019
View articletitled, A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma
Open the PDF for A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

Free
Amy K. Erbe, Wei Wang, Lakeesha Carmichael, KyungMann Kim, Eneida A. Mendonça, Yiqiang Song, Dustin Hess, Patrick K. Reville, Wendy B. London, Arlene Naranjo, Jacquelyn A. Hank, Mitchell B. Diccianni, Ralph A. Reisfeld, Stephen D. Gillies, Katherine K. Matthay, Susan L. Cohn, Michael D. Hogarty, John M. Maris, Julie R. Park, M. Fevzi Ozkaynak, Andrew L. Gilman, Alice L. Yu, Paul M. Sondel
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (1): 189–196.
https://doi.org/10.1158/1078-0432.CCR-17-1767
Published: 02 January 2018
View articletitled, Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group
Open the PDF for Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group in another window
Includes: Supplementary data
Journal Articles

Promising Therapeutic Targets in Neuroblastoma

Free
Katherine K. Matthay, Rani E. George, Alice L. Yu
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (10): 2740–2753.
https://doi.org/10.1158/1078-0432.CCR-11-1939
Published: 14 May 2012
View articletitled, Promising Therapeutic Targets in Neuroblastoma
Open the PDF for Promising Therapeutic Targets in Neuroblastoma in another window
Journal Articles

p16/p14ARF Cell Cycle Regulatory Pathways in Primary Neuroblastoma: p16 Expression Is Associated with Advanced Stage Disease

Free
Motoko Omura-Minamisawa, Mitchell B. Diccianni, Ray C. Chang, Ayse Batova, Louis J. Bridgeman, Jessica Schiff, Susan L. Cohn, Wendy B. London, Alice L. Yu
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (11): 3481–3490.
Published: 01 November 2001
View articletitled, p16/p14ARF Cell Cycle Regulatory Pathways in Primary Neuroblastoma: p16 Expression Is Associated with Advanced Stage Disease
Open the PDF for p16/p14ARF Cell Cycle Regulatory Pathways in Primary Neuroblastoma: p16 Expression Is Associated with Advanced Stage Disease in another window
Journal Articles

Ras Activation in Normal White Blood Cells and Childhood Acute Lymphoblastic Leukemia

Free
Friederike C. von Lintig, Ivana Huvar, Ping Law, Mitchell B. Diccianni, Alice L. Yu, Gerry R. Boss
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (5): 1804–1810.
Published: 01 May 2000
View articletitled, Ras Activation in Normal White Blood Cells and Childhood Acute Lymphoblastic Leukemia
Open the PDF for Ras Activation in Normal White Blood Cells and Childhood Acute Lymphoblastic Leukemia in another window
Journal Articles

Universal Inactivation of Both p16 and p15 but not Downstream Components Is an Essential Event in the Pathogenesis of T-Cell Acute Lymphoblastic Leukemia

Free
Motoko Omura-Minamisawa, Mitchell B. Diccianni, Ayse Batova, Ray C. Chang, Louis J. Bridgeman, John Yu, Jeanette Pullen, W. Paul Bowman, Alice L. Yu
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (4): 1219–1228.
Published: 01 April 2000
View articletitled, Universal Inactivation of Both p16 and p15 but not Downstream Components Is an Essential Event in the Pathogenesis of T-Cell Acute Lymphoblastic Leukemia
Open the PDF for Universal Inactivation of Both p16 and p15 but not Downstream Components Is an Essential Event in the Pathogenesis of T-Cell Acute Lymphoblastic Leukemia in another window
Journal Articles

The Ch14.18-GM-CSF Fusion Protein Is Effective at Mediating Antibody-dependent Cellular Cytotoxicity and Complement-dependent Cytotoxicity in Vitro

Free
Ayse Batova, Arvid Kamps, Stephen D. Gillies, Ralph A. Reisfeld, Alice L. Yu
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (12): 4259–4263.
Published: 01 December 1999
View articletitled, The Ch14.18-GM-CSF Fusion Protein Is Effective at Mediating Antibody-dependent Cellular Cytotoxicity and Complement-dependent Cytotoxicity in Vitro
Open the PDF for The Ch14.18-GM-CSF Fusion Protein Is Effective at Mediating Antibody-dependent Cellular Cytotoxicity and Complement-dependent Cytotoxicity in Vitro in another window